Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Artounian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Archives of Dermatological Research|November 30, 2022
Dermatology education resources on sun safety and skin cancer targeted at Spanish-speaking patients: a systematic reviewAntonio Ji-Xu, Kimberly Artounian, Emily M Altman
Medical Teacher|April 28, 2022
Absence of skin of colour images in online dermatology atlases and open-access datasetsAntonio Ji-Xu, Kimberly Artounian, Carine J Moezinia
JAAD Case Reports|March 18, 2025
A case to hear: Ears hard as rockLynn Midani, Kimberly Artounian, Sally Midani, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Applications of Gold and Silver Nanoparticles in the Treatment of Acne Vulgaris: A Systematic ReviewKimberly Artounian, Nour Bundogji, Elika Hoss, et al.
JAAD Case Reports|March 9, 2026
Small but mighty: Rhabdomyoblastic melanomaSurya A Veerabagu, Kimberly Artounian, Shelly Stepenaskie, et al.
Dermatology Online Journal|February 22, 2023
Trichodysplasia spinulosa: a presentation of polyomavirus infection in immunosuppressed patientsAntonio Ji-Xu, Kimberly Artounian, Maxwell A Fung, et al.
Journal of the American Academy of Dermatology|June 3, 2023
Factors associated with impaired quality of life and support group utilization in autoimmune bullous diseaseSamantha Herbert, Renee Haughton, Kimberly Artounian, et al.
Dermatologic Therapy|June 18, 2022
Omalizumab as adjuvant therapy for pemphigus vulgarisAntonio Ji-Xu, Kimberly Artounian, Maxwell A Fung, et al.
Clinical and Experimental Dermatology|June 14, 2022
Real-world utilization of Delphi consensus diagnostic criteria for suspected pyoderma gangrenosumAntonio Ji-Xu, William Liakos, Kimberly Artounian, et al.
The Journal of Investigative Dermatology|June 7, 2024
Pemphigus-Associated Desmoglein-Specific IgG1 and IgG4 Have a Dominant Agalactosylated Glycan ModificationArmin Oloumi, Stephanie T Le, Yiyun Liu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Dermatological Research|November 30, 2022
Dermatology education resources on sun safety and skin cancer targeted at Spanish-speaking patients: a systematic reviewAntonio Ji-Xu, Kimberly Artounian, Emily M Altman
Medical Teacher|April 28, 2022
Absence of skin of colour images in online dermatology atlases and open-access datasetsAntonio Ji-Xu, Kimberly Artounian, Carine J Moezinia
JAAD Case Reports|March 18, 2025
A case to hear: Ears hard as rockLynn Midani, Kimberly Artounian, Sally Midani, et al.
Journal of Drugs in Dermatology : JDD|June 2, 2021
Applications of Gold and Silver Nanoparticles in the Treatment of Acne Vulgaris: A Systematic ReviewKimberly Artounian, Nour Bundogji, Elika Hoss, et al.
JAAD Case Reports|March 9, 2026
Small but mighty: Rhabdomyoblastic melanomaSurya A Veerabagu, Kimberly Artounian, Shelly Stepenaskie, et al.
Dermatology Online Journal|February 22, 2023
Trichodysplasia spinulosa: a presentation of polyomavirus infection in immunosuppressed patientsAntonio Ji-Xu, Kimberly Artounian, Maxwell A Fung, et al.
Journal of the American Academy of Dermatology|June 3, 2023
Factors associated with impaired quality of life and support group utilization in autoimmune bullous diseaseSamantha Herbert, Renee Haughton, Kimberly Artounian, et al.
Dermatologic Therapy|June 18, 2022
Omalizumab as adjuvant therapy for pemphigus vulgarisAntonio Ji-Xu, Kimberly Artounian, Maxwell A Fung, et al.
Clinical and Experimental Dermatology|June 14, 2022
Real-world utilization of Delphi consensus diagnostic criteria for suspected pyoderma gangrenosumAntonio Ji-Xu, William Liakos, Kimberly Artounian, et al.
The Journal of Investigative Dermatology|June 7, 2024
Pemphigus-Associated Desmoglein-Specific IgG1 and IgG4 Have a Dominant Agalactosylated Glycan ModificationArmin Oloumi, Stephanie T Le, Yiyun Liu, et al.
Pageof 1